MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
According to ChainCatcher, strategic transformation information jointly led by Titan Partners Group and crypto investment firm GSR indicates that U.S. pharmaceutical company MEI Pharma (NASDAQ: MEIP) is advancing its dedicated Litecoin treasury strategy. More than $100 million in funding commitments have already been made to the project.
Notably, Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors. In addition, the Litecoin Foundation has invested in MEI Pharma, as the company’s treasury strategy closely aligns with the Foundation’s core mission of promoting global Litecoin adoption.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WLFI: WLFI Token Tradability Approved, Full Launch Expected in 6 to 8 Weeks
WLFI Increases Holdings of EGL1, LIBERTY, and B Tokens by $40,000 Each Again
A major whale accumulates another $69.8 million in ETH via FalconX
Trending news
MoreCrypto prices
More
